Sickle cell trait and severe maternal morbidity - 19/09/25
Doi : 10.1016/j.ajog.2025.05.019
Nansi S. Boghossian, PhD 
Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC
Ciaran S. Phibbs, PhD
Health Economics Resource Center and Center for Implementation to Innovation, Veterans Affairs Palo Alto Health Care System, Menlo Park, CA
Department of Pediatrics, Division of Neonatology, Stanford University School of Medicine, Stanford, CA
George R. Saade, MD
Department of Obstetrics & Gynecology, Eastern Virginia Medical School, Norfolk, VA
Jeannette Rogowski, PhD
Department of Health Policy and Administration, The Pennsylvania State University, State College, PA
Molly Passarella, MS
Roberts Center for Pediatric Research, Children's Hospital of Philadelphia, Philadelphia, PA
Jeffrey S. Buzas, PhD
Department of Mathematics and Statistics, University of Vermont, Burlington, VT
Scott A. Lorch, MD
Roberts Center for Pediatric Research, Children's Hospital of Philadelphia, Philadelphia, PA
Leonard Davis Institute of Health Economics, Wharton School, University of Pennsylvania, Philadelphia, PA
Video |
(6.5 Mo)
Key words : air and thrombotic embolism, blood transfusion, severe maternal morbidity, sickle cell trait
Plan
| Supported by the National Institute on Minority Health and Health Disparities R01MD016012 and the National Institute for Child Health and Human Development R01HD084819 and R01HD099197. |
|
| The authors report no conflict of interest. |
|
| The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The National Institutes of Health had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. |
|
| The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government. |
|
| The data will not be shared. Each state requires a data use agreement and does not allow the data to be shared. |
© 2025
Elsevier Inc. Tous droits réservés.
Vol 233 - N° 4
P. e132-e144 - octobre 2025 Retour au numéro
Article précédent
- Association of placenta accreta spectrum and vasa previa
- Yadira L. Bribiesca Leon, Shinya Matsuzaki, Zaira N. Chavez Jimenez, Fay F. Pon, Emi J. Komatsu, Jennifer A. Yao, Rachel S. Mandelbaum, Brian J. Gordon, Joseph G. Ouzounian, Koji Matsuo
- The frequency of placental lesions and adverse pregnancy outcomes: a linked cohort study
- Mauritia C. Marijnen, Carmen J.M. Oudejans, Alexa A. Freedman, Linda M. Ernst, Wessel Ganzevoort, Mirthe H. Schoots, Lotte-Elisabeth van der Meeren, S.J. Gordijn
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?